The Relationship between Inflammation or Bacterial Infection according to the Traditional 4-glass Tests or Tc-99m Ciprofloxacin Imaging and the Scores of the National Institute of Health-Chronic Prostatitis Symptom Index in Men with Chronic Prostatitis.
10.4111/kju.2006.47.8.870
- Author:
Jae Seung CHUNG
1
;
Do Hwan SEONG
;
Hun Jae LEE
;
Yeon Sook MOON
;
Jun Kyu SUH
Author Information
1. Department of Urology, Inha University College of Medicine, Incheon, Korea. jksuh@inha.ac.kr
- Publication Type:Original Article
- Keywords:
Prostatitis;
Pelvic Pain;
Questionnaires;
Radionuclide imaging
- MeSH:
Bacteria;
Bacterial Infections*;
Chlamydia trachomatis;
Ciprofloxacin*;
Humans;
Inflammation*;
Injections, Intravenous;
Male;
Mycoplasma hominis;
Pelvic Pain;
Pelvis;
Polymerase Chain Reaction;
Prostatitis*;
Quality of Life;
Surveys and Questionnaires;
Radionuclide Imaging;
Tomography, Emission-Computed, Single-Photon;
Ureaplasma urealyticum
- From:Korean Journal of Urology
2006;47(8):870-875
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We wanted to determine whether inflammation and bacterial infection, as tested for by the traditional 4-glass test or Tc-99m ciprofloxacin imaging, correlate with the symptom severity in men with chronic prostatitis. MATERIALS AND METHODS: The study included 256 patients with symptoms of prostatitis. The Korean version of the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI) was used to measure the symptoms of each patient. To diagnose bacterial infection, four-glass tests were performed that included culture for general bacteria, Mycoplasma hominis and Ureaplasma urealyticum, and polymerase chain reaction was performed for Chlamydia trachomatis. The patients with established uropathogens localized to the expressed prostatic secretion or the voided urine 3 were classified as having chronic bacterial prostatitis (CBP). To further localize the infection, the single photon emission computerized tomography images were obtained 3 hours after intravenous injection of Tc-99m ciprofloxacin. Associations between the symptoms and the inflammation and infection were evaluated. RESULTS: Based on the 4-glass tests, the patients were classified as CBP (n=16) or as chronic pelvis pain syndrome (CCPS) (the inflammatory type, n=94; non-inflammatory type, n=146). The CBP patients had a higher pain score than did the CPPS patients and there were no significant differences in the subscores for voiding symptoms and the quality of life between the groups. No significant differences were found in the total score or the subscores of the NIH-CPSI based on the presence or location of infection on the Tc-99m ciprofloxacin imaging. CONCLUSIONS: These findings suggest that bacterial infection, not inflammation, as determined by traditional laboratory tests contribute to the symptoms, especially pain, in men with chronic prostatitis.
